Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward



  • Novartis halts distribution of ranitidine products, generic for Zantac®, as precaution during investigation of possible contamination

    by
    • Optum for Workers' Compensation
    | Sep 19, 2019
    Tag Icon
    Pharmacy, Clinical, recall, FDA
    On September 18, 2019, Novartis announced it is stopping the distribution of its Sandoz division’s ranitidine, generic for Zantac®, until further notice. This decision was made as a result of the U.S. Food and Drug Administration (FDA) statement on September 13 that low levels of a human carcinogen were found in some ranitidine products.


  • FDA approves first alternative medications to Lyrica (pregabalin)

    by
    • Optum for Workers' Compensation
    | Jul 22, 2019
    Tag Icon
    Workers' Compensation, workers compensation, Medicare Insights, Settlement Solutions, Pain Management, Lyrica, Clinical
    Much anticipated alternative medications for Lyrica® (pregabalin) were approved by the U.S. Food and Drug Administration (FDA) on July 19, 2019. This approval follows a six-month delay announced last year. Pregabalin is an anticonvulsant with FDA approval to treat neuropathic (nerve) pain associated with diabetes, postherpetic neuralgia (shingles), fibromyalgia and neuropathic pain associated with spinal cord injury. In addition, it is approved as adjunct therapy for the treatment of partial onset seizures.


  • Colorado doctors can now recommend medical marijuana as opioid alternative

    by
    | Jun 13, 2019
    Tag Icon
    Clinical Intervention, Clinical, Opioids, Government Affairs, Medical Marijuana
    The Colorado legislature has passed a law permitting physicians to recommend marijuana in lieu of opioids to treat certain disabling medical conditions. Senate Bill 13, gives providers greater leeway in discussing pain treatment options with their patients and is scheduled to take effect August 2, 2019.


  • Minnesota enacts opioid prescribing limits

    by
    • Optum for Workers' Compensation
    | Jun 03, 2019
    Tag Icon
    Workers' Compensation, Opioids, Pain Management, Government Affairs, Clinical
    Minnesota has enacted legislation to address the opioid epidemic that includes opioid prescription and dispensing limitations for acute pain and initial prescriptions. The new policy expands upon prior narrower limitations. These new limitations take effect August 1, 2019.


  • Answers to Your Most Common Questions about Predictive Analytics in Workers’ Comp

    by
    • Optum for Workers' Compensation
    | May 16, 2019
    Tag Icon
    Analytics, Workers Comp, Clinical, Predictive Analytics
    Predictive analytics improve clinical outcomes and reduce costs for payers, but only if used properly. Risk & Insurance interviewed OWCA experts to learn how to apply predictive analytics in workers' compensation.


  • New Hampshire decision may open door for medical marijuana in workers’ comp

    by
    | Mar 14, 2019
    Tag Icon
    Pain Management, Workers Comp, workers compensation, Medical Marijuana
    Whether medical marijuana will be permitted in workers’ compensation is a hot topic. A recent Supreme Court decision in New Hampshire may open the door for medical marijuana in workers’ comp. Read more on our Policy Matters blog.


  • Register for 2019 Continuing Education

    by
    • Optum Workers' Comp
    | Jan 25, 2019
    Tag Icon
    Government Affairs, Webinar - Workers' Compensation, workers compensation, Settlement, Pharmacy, Pain Management, Clinical, Continuing Education
    From the state house, to the pharmacy, to claim resolution, Optum is kicking off its 2019 continuing education calendar with "What to watch for in 2019." See our full year of topics & register to gain the knowledge you need to move move forward this year!



Stay informed by receiving latest updates

Do you have a question about a blog post?

See more insights